T50.992A is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2022 edition of ICD-10-CM T50.992A became effective on October 1, 2021. This is the American ICD-10-CM version of T50.992A - other international versions of ICD-10 T50.992A may differ.
T43.505A is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2022 edition of ICD-10-CM T43.505A became effective on October 1, 2021. This is the American ICD-10-CM version of T43.505A - other international versions of ICD-10 T43.505A may differ.
2022 ICD-10-CM Diagnosis Code T43.506S T43.506S is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2022 edition of ICD-10-CM T43.506S became effective on October 1, 2021.
T38- Poisoning by, adverse effect of and underdosing of hormones and their synthetic substitutes and antagonists, not elsewhere classified T38.3X6A is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
Adverse effect of unspecified antipsychotics and neuroleptics, initial encounter. T43. 505A is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2022 edition of ICD-10-CM T43.
ICD-10 code F31. 81 for Bipolar II disorder is a medical classification as listed by WHO under the range - Mental, Behavioral and Neurodevelopmental disorders .
ICD-10 Code for Other long term (current) drug therapy- Z79. 899- Codify by AAPC.
Encounter for other specified aftercareICD-10 code Z51. 89 for Encounter for other specified aftercare is a medical classification as listed by WHO under the range - Factors influencing health status and contact with health services .
ICD-10 Code for Bipolar disorder, current episode manic severe with psychotic features- F31. 2- Codify by AAPC.
BD can be further subdivided into bipolar disorder I (BD I) and bipolar disorder II (BD II). The quintessential feature of BD I is the manifestation of at least one manic episode--although depressive episodes are common, only one manic episode in a lifetime is enough to label one with BD I.
Encounter for therapeutic drug level monitoring. Z51. 81 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
ICD-10 Code for Encounter for issue of repeat prescription- Z76. 0- Codify by AAPC.
The ICD-10 section that covers long-term drug therapy is Z79, with many subsections and specific diagnosis codes.
ICD-10 code Z51. 11 for Encounter for antineoplastic chemotherapy is a medical classification as listed by WHO under the range - Factors influencing health status and contact with health services .
Use Z codes to code for surgical aftercare. Z47. 89, Encounter for other orthopedic aftercare, and. Z47. 1, Aftercare following joint replacement surgery.
This second example uses Z09, which indicates surveillance following completed treatment of a disease, condition, or injury. Its use implies that the condition has been fully treated and no longer exists. Z09 would be used for all annual follow-up exams, provided no complications or symptoms are present.
Underdosing of insulin and oral hypoglycemic [antidiabetic] drugs, initial encounter 1 T38.3X6A is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. 2 Short description: Underdosing of insulin and oral hypoglycemic drugs, init 3 The 2021 edition of ICD-10-CM T38.3X6A became effective on October 1, 2020. 4 This is the American ICD-10-CM version of T38.3X6A - other international versions of ICD-10 T38.3X6A may differ.
mineralocorticoids and their antagonists ( T50.0-) oxytocic hormones ( T48.0-) parathyroid hormones and derivatives ( T50.9-) Poisoning by, adverse effect of and underdosing of hormones and their synthetic substitutes and antagonists, not elsewhere classified.
Use secondary code (s) from Chapter 20, External causes of morbidity, to indicate cause of injury. Codes within the T section that include the external cause do not require an additional external cause code. Type 1 Excludes.
The labeler code, product code, and package code segments of the National Drug Code number, separated by hyphens. Asterisks are no longer used or included within the product and package code segments to indicate certain configurations of the NDC.
The translation of the DosageForm Code submitted by the firm. The complete list of codes and translations can be found www.fda.gov/edrls under Structured Product Labeling Resources.
The labeler code, product code, and package code segments of the National Drug Code number, separated by hyphens. Asterisks are no longer used or included within the product and package code segments to indicate certain configurations of the NDC.
This corresponds to the NDA, ANDA, or BLA number reported by the labeler for products which have the corresponding Marketing Category designated. If the designated Marketing Category is OTC Monograph Final or OTC Monograph Not Final, then the Application number will be the CFR citation corresponding to the appropriate Monograph (e.g. “part 341”).